NCT04771039

Brief Summary

Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis in the literature (0.5% -3%), study on a large sample to assess their prevalence in patients with IBD at the Nancy CHRU and describe all the ocular manifestations that can be found.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2020

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

January 4, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 25, 2021

Completed
Last Updated

February 25, 2021

Status Verified

December 1, 2020

Enrollment Period

7.9 years

First QC Date

January 4, 2021

Last Update Submit

February 24, 2021

Conditions

Inflammatory Bowel DiseasesOphthalmopathy

Outcome Measures

Primary Outcomes (1)

  • frequency

    frequency of ocular manifestations in inflammatory bowel disease

    baseline

Secondary Outcomes (1)

  • Number

    baseline

Study Arms (1)

patients with chronic inflammatory bowel disease who consulted in ophthalmology

Other: reason for consultation

Interventions

reason for consultationOTHER

search in medical files for reasons for ophthalmology consultation, functional signs, clinical signs, treatment, characteristics of IBD

patients with chronic inflammatory bowel disease who consulted in ophthalmology

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients followed at Nancy University Hospital for IBD and having consulted in the ophthalmology department

You may qualify if:

  • Adult patients followed at Nancy University Hospital for IBD and having consulted in the ophthalmology department

You may not qualify if:

  • Minor patients
  • patients without IBD
  • patients for whom there is no ophthalmology consultation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Inflammatory Bowel DiseasesEye Diseases

Interventions

Referral and Consultation

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2021

First Posted

February 25, 2021

Study Start

January 1, 2013

Primary Completion

December 1, 2020

Study Completion

December 12, 2020

Last Updated

February 25, 2021

Record last verified: 2020-12